CD274 and neoplasm: Patients with colon cancer exhibiting a lower m6Sig score demonstrated prolonged survival, enhanced immune infiltration, and a correlation with increased tumor mutation burden, PD-L1 expression, and higher mutation rates in significant mutation genes (SMGs) such as PIK3CA and SMAD4 [145].